אזהרות
Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement – Recommendation to Discontinue Prescribing and Dispensing
מערכת האתר
10:25
סגור לתגובות על Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement – Recommendation to Discontinue Prescribing and Dispensing
FDA is recommending
Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement – Recommendation to Discontinue Prescribing and Dispensing
בעז גנזבורג
17:33
סגור לתגובות על Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement – Recommendation to Discontinue Prescribing and Dispensing
AUDIENCE: Consumer, Dentistry, Emergency Medicine, Internal Medicine, Pharmacy, Pain Management, Surgery ISSUE: FDA is recommending health care professionals discontinue prescribing
Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication – Removal of Some Prescribing and Dispensing Restrictions
בעז גנזבורג
10:56
סגור לתגובות על Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication – Removal of Some Prescribing and Dispensing Restrictions
FDA has determined
Hydroxyethyl Starch Solutions: FDA Safety Communication – Boxed Warning on Increased Mortality and Severe Renal Injury and Risk of Bleeding
מערכת האתר
10:22
סגור לתגובות על Hydroxyethyl Starch Solutions: FDA Safety Communication – Boxed Warning on Increased Mortality and Severe Renal Injury and Risk of Bleeding
FDA has analyzed recent data that indicate an
Fluoroquinolone Antibacterial Drugs: Drug Safety Communication- Risk for possibly permanent nerve damage
מערכת האתר
13:09
סגור לתגובות על Fluoroquinolone Antibacterial Drugs: Drug Safety Communication- Risk for possibly permanent nerve damage
FDA has required the drug labels and Medication Guides for all fluoroquinolone
FDA Warns of Fatal Skin Reactions with Acetaminophen
מערכת האתר
15:54
סגור לתגובות על FDA Warns of Fatal Skin Reactions with Acetaminophen
SILVER SPRING, Md.
עדכונים לגבי אזהרות שימוש בתרופות מנובמבר 2011 ואילך
עדכונים לגבי אזהרות שימוש בתרופות מנובמבר 2011 ואילך מפורסמים באתר משרד הבריאות
